GENE ONLINE|News &
Opinion
Blog

2025-03-04|

Study Reveals How ‘Two-Hit Stress’ During Pregnancy Impacts Brain and Behavior in Mice

by Mark Chiang
Share To

A new study sheds light on the profound effects of prenatal and postnatal stress on brain development and behavior, using mice as a model. Researchers have found that a combination of stressors—termed “two-hit stress”—can significantly influence emotional outcomes later in life.**

The concept of two-hit stress refers to an initial traumatic event, such as an infection during pregnancy, followed by social stress experienced during postpartum development. This dual exposure appears to create a compounded effect on the offspring’s neurological and emotional health.

The findings suggest that infections occurring in the womb may alter brain development in ways that make individuals more vulnerable to subsequent environmental stressors. These changes could manifest as heightened emotional sensitivity or behavioral challenges later in life.

While the research was conducted on mice, it opens up important avenues for understanding how prenatal and early-life experiences shape long-term mental health outcomes in humans. The study underscores the importance of addressing maternal health during pregnancy and providing supportive environments for early childhood development.

Date: March 3, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Study Finds Timing of Prenatal Stress Influences Infant Stress Responses by Gender
2025-03-12
Study Finds Connection Between Social Media Use and Delusion-Based Disorders
2025-03-12
Study Links Childhood Abuse to Increased Risk of Chronic Health and Psychiatric Issues
2025-03-12
LATEST
AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing
2025-03-19
Edge Computing: The Next Big Thing in AI and Automation
2025-03-19
Neurosurgery Now: NVIDIA’s Holoscan AI Brings Real-Time 3D Vision to Enhance Surgical Precision at 2025 GTC
2025-03-18
NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery
2025-03-18
AstraZeneca Acquires Cell Therapy Company in $1 Billion Deal to Develop In Vivo Cancer Treatments
2025-03-18
Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient
2025-03-17
NICE Recommends New Endometriosis Treatment for NHS Patients
2025-03-14
EVENT
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
Scroll to Top